Boston Scientific (NYSE:BSX – Get Free Report) had its price target upped by equities researchers at Canaccord Genuity Group from $98.00 to $101.00 in a research report issued on Monday,Benzinga ...
To truly make a difference, scientific innovation must translate into tangible benefits for society. VinFuture's award criteria reflect this commitment to recognizing research with real-world ...